Evidence from a recent study, led by MSK urologic surgeon, Behfar Ehdaie, MD, MPH, indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active ...

Background: Active surveillance is considered a mainstream strategy in the management of patients with low-risk prostate cancer. A mission-critical step in implementing a robust active ...

Because prostate cancer cells usually grow very slowly, some men might not need treatment right away. Your doctor might suggest something called active surveillance. That means instead of having ...

It’s crucial for patients with prostate cancer to know that all treatments come with side effects, which may affect their ...

Study by @HopkinsMedicine @brady_urology in @JAMAOnc (bit.ly/4e6bfAd) shows — for what is believed to be the 1st time — that ...

However, although a PSA velocity greater than 2.0 identified 100% of patients dying of prostate cancer within 10 years of surgery in the D'Amico group, cause-specific survival at 10 years in this ...

National health organizations recommend screening begin at age 40 for high-risk men and age 45 for average-risk men.

A study in JAMA Oncology links dietary quality to prostate cancer grade reclassification risk, suggesting healthier diets may ...

Higher adherence to American dietary guideline recommendations may be associated with a lower risk for grade reclass ...

Baseline MRI PI-RADS score suggests prognosis and may improve upfront risk stratification and eligibility for prostate cancer active surveillance. Higher baseline MRI PI-RADS score is associated ...

But despite this good news, the overall number of new prostate cancer cases and deaths is on the rise in the U.S.: 2014: 182,806 new prostate cancer cases 2019: 224,733 new prostate cancer cases ...

Professor in urologic oncology at the Johns Hopkins University School of Medicine and director of the Brady Urological Institute’s prostate cancer active surveillance program. Prostate cancer is ...